trending Market Intelligence /marketintelligence/en/news-insights/trending/NukndsFsU75KJtxa8OfSDA2 content esgSubNav
In This List

Riken Vitamin fiscal Q3 profit falls YOY

Podcast

Next in Tech | Episode 50: InfoSec spending up, again…

Blog

Broadcast deal market recap 2021

Podcast

Next in Tech | Episode 49: Carbon reduction in cloud

Blog

Price wars in India: Disney+ Hotstar vs. Amazon Prime Video vs. Netflix


Riken Vitamin fiscal Q3 profit falls YOY

Riken Vitamin Co. Ltd. said its normalized net income for the fiscal third quarter ended Dec. 31, 2014, came to ¥39.14 per share, a decline of 20.3% from ¥49.09 per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥865.4 million, a decrease of 20.3% from ¥1.09 billion in the prior-year period.

The normalized profit margin fell to 4.0% from 4.9% in the year-earlier period.

Total revenue declined year over year to ¥21.66 billion from ¥21.94 billion, and total operating expenses came to ¥20.40 billion, compared with ¥20.31 billion in the year-earlier period.

Reported net income totaled ¥1.21 billion, or ¥54.77 per share, compared to ¥1.22 billion, or ¥55.31 per share, in the year-earlier period.

As of Feb. 12, US$1 was equivalent to ¥118.90.